Innovation areas

We aim to address patient needs through transformational innovation. We bring together the best science, technology and next-generation biological capabilities from inside and outside our company.

Learn more about our approach in small molecules, biologicals and cell therapy.

Reduce risk and accelerate time-to-patients

Combining deep disease expertise and multiple drug modalities

Small molecules

We are grounded in a long history of research into small molecules

Cell therapy

We have groundbreaking research capabilities and a decentralized manufacturing platform for CAR-T

Biologicals

We are building unique research ​capabilities to discover novel biological medicines

John Mellors

Head of Cell and Antibody Therapy Discovery

We focus on paradigm-shifting science and biological capabilities such as multi-targeting CAR-Ts, antibodies and fully-human antibody engineering.

Pipeline

Diversifying and accelerating our pipeline

We focus on delivering best-in-class medicines with transformational impact for patients by accelerating life-changing science and innovation in the fields of immunology and oncology.

Disease areas

Pioneering for patients

We know that patients in need are waiting. That is why we focus on therapeutic areas where we aim to make transformational impact happen faster, including oncology and immunology.

Our stories

More about our company, science and people

We curate a series of inspiring stories about how we are #LivingInnovation at Galapagos

Partnerships

Work with us!

We are adding new capabilities, technologies and product candidates through internal and external innovation. Let’s start #PioneeringForPatients, together!

Galapagos Health

Explore our HCP Portal

Are you a healthcare professional, and do you need the latest on our products, medical information and events?